Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Prevail Therapeutics Inc. (PRVL)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-19Dec-31-18
   10-K10-K
Revenues   [+]0.00.1
            Revenue growth  -100.0% 
Cost of goods sold  0.00.1
Gross profit  0.00.0
            Gross margin   0.0%
Selling, general and administrative   [+]17.04.7
Research and development  48.814.1
EBITDA   [+]-65.5-18.8
            EBITDA margin   -21556.3%
Depreciation and amortization  0.30.1
EBIT   [+]-65.8-18.8
            EBIT margin   -21619.5%
Interest income, net   [+]2.60.4
Other income (expense), net   -0.7
Pre-tax income  -63.2-19.1
Income taxes  0.00.0
            Tax rate  0.0%0.0%
Net income  -63.2-19.1
            Net margin   -21939.1%
   
Basic EPS   [+]($2.22)($3.71)
Diluted EPS   [+]($2.22)($3.71)
   
Shares outstanding (basic)   [+]28.55.1
Shares outstanding (diluted)   [+]28.55.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy